Literature DB >> 15179026

Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.

Jordi Riba1, Peter Anderer, Francesc Jané, Bernd Saletu, Manel J Barbanoj.   

Abstract

Ayahuasca, a South American psychotropic plant tea obtained from Banisteriopsis caapi and Psychotria viridis, combines monoamine oxidase-inhibiting beta-carboline alkaloids with N,N-dimethyltryptamine (DMT), a psychedelic agent showing 5-HT(2A) agonist activity. In a clinical research setting, ayahuasca has demonstrated a combined stimulatory and psychedelic effect profile, as measured by subjective effect self-assessment instruments and dose-dependent changes in spontaneous brain electrical activity, which parallel the time course of subjective effects. In the present study, the spatial distribution of ayahuasca-induced changes in brain electrical activity was investigated by means of low-resolution electromagnetic tomography (LORETA). Electroencephalography recordings were obtained from 18 volunteers after the administration of a dose of encapsulated freeze-dried ayahuasca containing 0.85 mg DMT/kg body weight and placebo. The intracerebral power density distribution was computed with LORETA from spectrally analyzed data, and subjective effects were measured by means of the Hallucinogen Rating Scale (HRS). Statistically significant differences compared to placebo were observed for LORETA power 60 and 90 min after dosing, together with increases in all six scales of the HRS. Ayahuasca decreased power density in the alpha-2, delta, theta and beta-1 frequency bands. Power decreases in the delta, alpha-2 and beta-1 bands were found predominantly over the temporo-parieto-occipital junction, whereas theta power was reduced in the temporomedial cortex and in frontomedial regions. The present results suggest the involvement of unimodal and heteromodal association cortex and limbic structures in the psychological effects elicited by ayahuasca. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15179026     DOI: 10.1159/000077946

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  33 in total

1.  Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.

Authors:  Michael Kometer; Thomas Pokorny; Erich Seifritz; Franz X Volleinweider
Journal:  Psychopharmacology (Berl)       Date:  2015-08-01       Impact factor: 4.530

2.  Influence of ocular filtering in EEG data on the assessment of drug-induced effects on the brain.

Authors:  Sergio Romero; Miguel A Mañanas; Manel J Barbanoj
Journal:  Hum Brain Mapp       Date:  2009-05       Impact factor: 5.038

3.  Evaluation of multiple comparison correction procedures in drug assessment studies using LORETA maps.

Authors:  Joan Francesc Alonso; Sergio Romero; Miguel Ángel Mañanas; Mónica Rojas; Jordi Riba; Manel José Barbanoj
Journal:  Med Biol Eng Comput       Date:  2015-06-04       Impact factor: 2.602

4.  Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?

Authors:  Benjamin J Malcolm; Kelly C Lee
Journal:  Ment Health Clin       Date:  2018-03-23

Review 5.  The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.

Authors:  Robin L Carhart-Harris; Guy M Goodwin
Journal:  Neuropsychopharmacology       Date:  2017-04-26       Impact factor: 7.853

6.  LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion.

Authors:  Leor Roseman; Martin I Sereno; Robert Leech; Mendel Kaelen; Csaba Orban; John McGonigle; Amanda Feilding; David J Nutt; Robin L Carhart-Harris
Journal:  Hum Brain Mapp       Date:  2016-04-29       Impact factor: 5.038

7.  Acute and post-acute behavioral and psychological effects of salvinorin A in humans.

Authors:  Peter H Addy
Journal:  Psychopharmacology (Berl)       Date:  2011-09-08       Impact factor: 4.530

8.  High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.

Authors:  Chad J Reissig; Lawrence P Carter; Matthew W Johnson; Miriam Z Mintzer; Margaret A Klinedinst; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2012-04-13       Impact factor: 4.530

Review 9.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332

Review 10.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.